In the risk model, the methylation level of CASP1 was negatively correlated with the risk score, indicating that the high expression of CASP1 was a high-risk factor, which might be related to CASP1’s activation of IL-1β, inducing inflammation and immunosuppression to promote tumor growth and metastasis [43]. Here, CASP1 is linked to neoplasm.